If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder

September 30, 2011

More Overactive Bladder Clinical Trials

Painless Laser Therapy for Overactive Bladder (PLTOAB)
A Study to Investigate How Effective and Safe Solifenacin Liquid Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug (LION)
Study of Overactive Bladder in Women With Prolapse (SOAP)
Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily
Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

More in Overactive Bladder Clinical Trials:

Comparative Urine Proteomic Studies of Overactive Bladder in Humans

Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder

Sponsor and Collaborators
Adana Numune Training and Research Hospital Kocaeli University Akdeniz University Cukurova University Baskent University Ankara University Gaziantep University Inonu University Gaziosmanpasa University Kahramanmaras Sutcu Imam University

Contact
Murat Api, MD, PhD
905424241807
muratapi@hotmail.com

Study Director
Murat Api, MD, PhD
Turkish Republic Ministry of Health Adana Numune Training and Research Hospital

ClinicalTrials.gov Identifier
NCT01423838